8 completed. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 1 | Completed 1 |
Follow Ileus: new trials by email Literature Review of Ileus trials Research Report on Ileus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) Eluxadoline, Placebo - Irritable Bowel Syndrome | Phase 3 | Completed | Furiex Pharmaceuticals, Inc | 1146 | 2012-05-29 | 2018-07-30 |
| The Effects of Gum Chewing on Bowel Function Recovery Following Cesarean Section Gum chewing - Paralytic Ileus | Phase 2 / Phase 3 | Completed | Chiang Mai University | 100 | 2010-05-01 | 2011-06-28 |
| A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair MOA-728, Placebo - Ileus | Phase 3 | Completed | Bausch Health Americas, Inc. | 374 | 2007-10-17 | 2019-09-04 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 660 | 2004-06-01 | 2016-01-11 |
| Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery Luminal stents, Minimally Invasive Surgical Bowel Diversion - Large Bowel Obstruction | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 180 | 2002-12-01 | 2007-12-10 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 510 | 2002-01-01 | 2015-07-20 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 666 | 2001-12-01 | 2015-07-20 |
| Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus Alvimopan - Ileus | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 451 | 2001-03-01 | 2017-08-22 |
Colonic Pseudo-Obstruction (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Diarrhea (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Hernia (1) · Intestinal Diseases (1) · Intestinal Pseudo-Obstruction (1) · Irritable Bowel Syndrome (1) · Signs and Symptoms, Digestive (1)
Intestinal Obstruction (8) · Digestive System Diseases (7) · Gastrointestinal Diseases (7) · Intestinal Diseases (7) · Intestinal Pseudo-Obstruction (2) · Pathological Conditions, Signs and Symptoms (2) · Colonic Diseases (1) · Colonic Diseases, Functional (1) · Pathological Conditions, Anatomical (1) · Signs and Symptoms (1)
alvimopan (4) · Chewing Gum (1) · eluxadoline (1) · methylnaltrexone (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (4) · Bausch Health Americas, Inc. (1) · Chiang Mai University (1) · Furiex Pharmaceuticals, Inc (1) · Memorial Sloan Kettering Cancer Center (1)
United States (7) · Canada (2) · Australia (1) · Belgium (1) · Germany (1) · Hungary (1) · Italy (1) · Netherlands (1) · Poland (1) · Puerto Rico (1) · South Africa (1) · South Korea (1) · Thailand (1) · United Kingdom (1)
Hans Gerdes, M.D. (1) · Kittipat Charoenkwan, MD (1) · Lindsey Mathew (1)
PMID 20526599, PMID 15383800, PMID 15906123, PMID 16333556, PMID 19015469, PMID 26789872, PMID 28167156